市場調查報告書
商品編碼
1386274
自體幹細胞和非幹細胞療法市場報告:2030 年趨勢、預測和競爭分析Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
自體幹細胞和非幹細胞治療趨勢和預測
至2030年,全球自體幹細胞和非幹細胞治療市場預計將達到130億美元,2024年至2030年的年複合成長率為10.2%。該市場的主要驅動力是對微創治療的需求不斷成長、幹細胞和非幹細胞治療方法的快速技術進步以及政府對促進再生醫學應用的支持不斷增加。全球自體幹細胞和非幹細胞治療市場的未來前景廣闊,醫院和門診手術中心市場充滿機會。
自體幹細胞與非幹細胞治療市場洞察
Lucintel 預測,由於癌症盛行率和治療方法的擴大,以及自體幹細胞治療的使用不斷增加,癌症和腫瘤學預計將在預測期內實現最高成長。
由於慢性病的高盛行率、對微創治療的巨大需求以及有利的政府報銷政策的存在,預計北美在預測期內將出現最高的成長。
Autologous Stem Cell and Non-Stem Cell Based Therapy Trends and Forecast
The future of the global autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.
A more than 150-page report is developed to help in your business decisions.
Autologous Stem Cell and Non-Stem Cell Based Therapy by Segment
The study includes a forecast for the global autologous stem cell and non-stem cell based therapy by product type, type, application, end use, and region.
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Autologous Stem Cell and Non-Stem Cell Based Therapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autologous stem cell and non-stem cell based therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autologous stem cell and non-stem cell based therapy companies profiled in this report include-
Autologous Stem Cell and Non-Stem Cell Based Therapy Market Insights
Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.
North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.
Features of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
Market Size Estimates: Autologous stem cell and non-stem cell based therapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Autologous stem cell and non-stem cell based therapy market size by various segments, such as by product type, type, application, end use, and region in terms of ($B).
Regional Analysis: Autologous stem cell and non-stem cell based therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, types, applications, end uses, and regions for the autologous stem cell and non-stem cell based therapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autologous stem cell and non-stem cell based therapy market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the autologous stem cell and non-stem cell based therapy market size?
Answer: The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030.
Q.2 What is the growth forecast for autologous stem cell and non-stem cell based therapy market?
Answer: The global autologous stem cell and non-stem cell based therapy market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the autologous stem cell and non-stem cell based therapy market?
Answer: The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.
Q4. What are the major segments for autologous stem cell and non-stem cell based therapy market?
Answer: The future of the autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets.
Q5. Who are the key autologous stem cell and non-stem cell based therapy market companies?
Answer: Some of the key autologous stem cell and non-stem cell based therapy companies are as follows:
Q6. Which autologous stem cell and non-stem cell based therapy market segment will be the largest in future?
Answer: Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.
Q7. In autologous stem cell and non-stem cell based therapy market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.